Log inSign up
AAOIFI No. 21 screening

Is ALKS halal?

Alkermes plc

Not halal

Alkermes plc did not pass AAOIFI screening. The failed check is shown below.

Checked: 15 October 2026

Exchange

NASDAQ

Price

41.22

Day

+2.79%

Market cap

$6.71B

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

What the company does

Alkermes (Ireland/US) makes drugs for psychiatric illness and addiction: Vivitrol (opioid/alcohol dependence), Aristada (schizophrenia) and Lybalvi. Revenue comes from drug sales and licensing royalties.

What was checked

The AAOIFI standard has four steps: business activity first, then three financial ratios. Fail one and the stock is not halal.

  • Business activity

    No prohibited activity

  • Interest-bearing debt / market cap

    limit 30%

    Interest-bearing debt $1.51B ÷ 36-month average market cap $4.81B = 31.4%

    31.4%

    Fail

  • Cash & investments / market cap

    limit 30%

    Cash + interest-bearing securities $538.08M ÷ 36-month average market cap $4.81B = 11.2%

    11.2%

    Pass

  • Non-compliant income / total revenue

    limit 5%

    Interest income $45.30M ÷ annual revenue $1.48B (2025) = 3.1%

    3.1%

    Pass

Figures from the company's filings (2026-03-31), USD. Market cap is a 36-month average (the S&P Shariah index approach), so a one-day price move does not flip the verdict. Today's market cap: $6.71B.

For information (AAOIFI 3/1 note): cash + receivables are 21.6% of total assets (2026-03-31). AAOIFI recommends tangible assets of at least one third — this figure does not affect the verdict, and other major screeners do not apply it either.

In the lists

In the S&P 500
Not in the S&P 500

Halal stocks in the same industry

The largest halal stocks in Drug Manufacturers - Specialty & Generic — for comparison.

Related articles

Halal is the first question. The second: when to enter?

Our scanner watches 1454 halal stocks around the clock and fires a signal with entry, TP and SL when a technical setup completes. The full signal history — with outcomes — is public.

This is neither investment advice nor a fatwa. Screening is based on public financial statements and AAOIFI standard No. 21; data may lag. For a personal decision consult your own scholar.

Earnings historyALKS's next report date, EPS estimate vs actual for recent quarters and the post-earnings price move.View earnings →